Class 2 Medicines Recall: Nitrofurantoin Cnx Therapeutics 100 Mg Prolonged-release Capsules, El(25)a/05
Recall Summary CNX Therapeutics is recalling specific batches of Nitrofurantoin 100 mg prolonged-release capsules in the United Kingdom because some packs contain an extra tablet inside the capsule. The product is supposed to contain powder and two yellow tablets, but affected packs have an additional tablet. This is a Class II recall.
- Recalling firm
- Nitrofurantoin CNX Therapeutics 100 mg Prolonged-Release capsules
- Reason
- CNX Therapeutics is recalling the batches listed in this notification as a precautionary measure due to a small number of packs that contain an additional tablet of Nitrofurantoin. The registered product is a capsule containing powder and two yellow tablets.
- Classification
- Class II
- Category
- drug recall
- Country
- United Kingdom
- Agency
- UK Medicines and Healthcare products Regulatory Agency
- Recall date
- 2025-02-05
- Status
- Ongoing
- Distribution
- United Kingdom
Official recall notice from UK Medicines and Healthcare products Regulatory Agency
Recall details on Nibble Recalls: https://trynibble.app/recalls/2edcd17d-a07f-40e8-aa60-35f695cf4092